DIAGNOS (OTCMKTS:DGNOF) Issues Earnings Results

DIAGNOS (OTCMKTS:DGNOFGet Free Report) announced its earnings results on Thursday. The company reported ($0.01) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.01), Zacks reports.

DIAGNOS Price Performance

Shares of OTCMKTS DGNOF traded down $0.00 during midday trading on Thursday, reaching $0.14. The stock had a trading volume of 107,500 shares, compared to its average volume of 100,062. The stock has a 50-day moving average of $0.16 and a 200-day moving average of $0.20. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.75 and a current ratio of 1.75. The company has a market capitalization of $16.27 million, a price-to-earnings ratio of -3.38 and a beta of -0.09. DIAGNOS has a 12-month low of $0.13 and a 12-month high of $0.29.

About DIAGNOS

(Get Free Report)

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.

Read More

Earnings History for DIAGNOS (OTCMKTS:DGNOF)

Receive News & Ratings for DIAGNOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIAGNOS and related companies with MarketBeat.com's FREE daily email newsletter.